{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "alcohol-based hand rub",
      "alcohol-based hand sanitizer",
      "hand hygiene",
      "hand sanitizer"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Lay abstract The virus responsible of COVID-19 pandemic, SARS-CoV-2, can be inactivated by ethanol. This study evaluates the ability of an alcohol-based hand sanitizer (Amuchina Gel Xgerm, 74% ethanol) to kill SARS-CoV-2, according to the European Standard guidelines. Amuchina Gel Xgerm completely inactivates the virus after 30\u00a0s of exposure. This result supports the effectiveness of this alcohol-based formulation as a prevention measure for COVID-19."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34165328",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2217/fmb-2021-0128"
    ],
    "Journal": {
      "ISSN": "1746-0921",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Jul"
        }
      },
      "Title": "Future microbiology",
      "ISOAbbreviation": "Future Microbiol"
    },
    "ArticleTitle": "Amuchina Gel Xgerm hand rub <i>in vitro</i> virucidal activity against SARS-CoV-2.",
    "Pagination": {
      "StartPage": "797",
      "EndPage": "800",
      "MedlinePgn": "797-800"
    },
    "Abstract": {
      "AbstractText": [
        "<b>Aim:</b> Ethanol is highly effective at inactivating enveloped viruses, including SARS-CoV-2. The aim of this study is to evaluate the virucidal activity of Amuchina Gel Xgerm (74% ethanol) against SARS-CoV-2, according to the European Standard EN14476:2013+A2:2019. <b>Materials & methods:</b> Virucidal activity of the study product was evaluated against SARS-CoV-2 strain USAWA1/2020 in suspension, in the presence of 0.3\u00a0g/l\u00a0of bovine serum albumin. <b>Results:</b> The log<sub>10</sub> reduction of SARS-CoV-2 in the presence of bovine serum albumin\u00a0was \u22654.11\u00a0\u00b1\u00a00.12 after 30\u00a0s of exposure to the study product (80% dilution). Cytotoxicity was observed in the 10<sup>0</sup> dilution, affecting the detection limit by 1 log<sub>10</sub>. <b>Conclusion:</b> Virucidal activity against SARS-CoV-2 supports the effectiveness of this alcohol-based formulation as a prevention measure for COVID-19 illness."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Angelini Pharma S.p.A, Via Vecchia del Pinocchio, Ancona, 22 -\u00a060131, Italy."
          }
        ],
        "LastName": "de Joannon",
        "ForeName": "Alessandra Capezzone",
        "Initials": "AC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Angelini Pharma S.p.A, Viale Amelia, Rome, 70 -\u00a000181, Italy."
          }
        ],
        "LastName": "Testa",
        "ForeName": "Angela",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Angelini Pharma S.p.A, Viale Amelia, Rome, 70 -\u00a000181, Italy."
          }
        ],
        "LastName": "Falsetto",
        "ForeName": "Natalie",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Angelini Pharma S.p.A, Viale Amelia, Rome, 70 -\u00a000181, Italy."
          }
        ],
        "LastName": "Procaccini",
        "ForeName": "Michela",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Angelini Pharma S.p.A, Via Vecchia del Pinocchio, Ancona, 22 -\u00a060131, Italy."
          }
        ],
        "LastName": "Ragni",
        "ForeName": "Lorella",
        "Initials": "L"
      }
    ],
    "GrantList": [
      {
        "Agency": "Angelini Pharma SpA",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Future Microbiol",
    "NlmUniqueID": "101278120",
    "ISSNLinking": "1746-0913"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Hand Sanitizers"
    },
    {
      "RegistryNumber": "3K9958V90M",
      "NameOfSubstance": "Ethanol"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Ethanol"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Hand Hygiene"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Hand Sanitizers"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}